renalgenie tutorial - rescheduling medications with improved amount calculation
Published 4 months ago • 8 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
2:11
rebyota trial subgroup analysis: results for people with renal comorbidities | idweek 2023
-
3:46
results of the phase iii persist-1 trial of pacritinib for myelofibrosis
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
17:22
critical appraisal of randomised controlled trial (rct) - remdesivir vs placebo in covid-19
-
1:35
an overview of the main challenges to prolonging remission in aml
-
3:40
outcomes of all stratified by socioeconomic factors
-
1:03
insights into the cartitude-6 trial: rationale and design
-
1:02:03
cirs evaluation & toolkit (chronic inflammatory response syndrome)
-
11:48
superar la enfermedad renal gracias a los 3 secretos impresionantes de frank suarez
-
48:19
enfermedad renal crónica: nefropatía diabética #nefrología
-
5:41
primary results from the phase iii shine study: ibrutinib br for older patients with mcl
-
1:44
real-world outcomes of brexu-cel for r/r b-all: evidence from the cibmtr registry
-
1:18
determining complete remission in patients with aml
-
1:26
unmet needs that remain in stage 3b and r/r amyloidosis
-
![[multidisciplinary] m3(r2)](https://i.ytimg.com/vi/O3JJjeh13SU/mqdefault.jpg)
1:01:31
[multidisciplinary] m3(r2)
-
1:05
improving transplantation rates by increasing cr in aml
-
1:10:53
november 21, 2022 nephrology vmr with dr. letícia rolon and dr. david li - hematuria & recurrent aki
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:04
phase ii trial of nivolumab and relatlimab in mss crc
-
6:35
measuring residual disease in granulocytes to predict relapse after therapy cessation in cml
-
3:01
hospital diabetes by krystal m. renszel, do | preview